WHO vaccine-preventable diseases: monitoring system. 2015 global summary

Last updated 15-Jul-2015 (Data received as of 10-Jul-2015)
Next overall update Fall 2015
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 8601 Infant (under 12 months) mortality rate: 562
GDP / capita (US$): 1'8591 Child (under 5 years) mortality rate: 902

Population data in thousands3

  2014  2013  2012  2011  2010  2000  1990  1980 
Total population 14'599  14'150  13'724  13'359  13'077  12'504  10'462  7'289 
Births 452  446  439  434  429  398  387  344 
Surviving infants 436  429  422  416  411  370  364  321 
Pop. less than 5 years 2'078  2'042  2'010  1'979  1'950  1'809  1'775  1'454 
Pop. less than 15 years 5'688  5'583  5'493  5'428  5'392  5'271  4'822  3'567 
Female 15-49 years 3'752  3'596  3'446  3'309  3'195  3'046  2'364  1'531 

Number of reported case

(Click for retrospective incidence data for Zimbabwe)
Diphtheria
Japanese encephalitis
Measles 9'696  1'483  13'728  23'650 
Mumps
Pertussis 491  6'290 
Polio* 32 
Rubella 1'130  130  20  447 
Rubella (CRS) 63 
Tetanus (neonatal) 16  16  134 
Tetanus (total)** 28  139 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Zimbabwe)
Vaccine year result method % card seen                                                
BCG 2013  95  MICS   81  99  95  98  98  99*  82  74 
DTP1 2013  95  MICS   81  98  98  99  99  95  90 
DTP3 2013  87  MICS   81  91  95  95  93  89  77  78 
DTP4          83 
IPV1         
HepB_BD          90 
HepB3 2013  87  MICS   81  91  95  93  89  77 
Hib3 2013  87  MICS   81  91  95  93  89 
JapEnc         
MCV1          92  93  97  92  90  70  76 
MCV2         
PCV1          98  98  99 
PCV3 2013  73  MICS   81  91  95  95 
Pol3 2013  88  MICS   81  92  95  95  93  89  70  78 
Rota1          94 
Rota_last          82 
Rubella1         
TT2plus 2013  32  MICS   81  58  75  85  80  60  60  43 
PAB         
VAD1          49  19  95  91  95 
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: Mid July 2016

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Zimbabwe)
BCG 99  95  98  98  99  84  91 
DTP1 98  98  99  99  95  84  96 
DTP3 91  95  95  93  89  78  88 
HepB3 91  93  95  93  89  79 
HepB_BD
Hib3 91  93  95  93  89 
MCV1 92  93  97  92  90  75  87 
MCV2
PAB 75  66  66  66  76  76  57 
PCV3 91  95  21 
Pol3 92  95  95  93  89  78  89 
Rota_last 48 

Number of districts in the country 63  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 54
From 80 to 89% 37
From 50 to 79% 10
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2014 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwP 18 months; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
HPV 10 years; +6 months; No 10-13 years
IPV 14 weeks; Yes From October 2015
MR 9, 18 months; Yes From June 2015
Measles 9 months; Yes
OPV 6, 10, 14 weeks; 18 months; Yes
Pneumo_conj 6, 10, 14 weeks; Yes
Rotavirus 6, 10 weeks; Yes
TT 1st contact; +4 weeks; +6 months; Yes CBAW
VitaminA 6, 12, 18, 24, 30, 36 months; Yes

Immunizaton indicators

Indicator Expected answer 2014  2013  2012  2011  2010  2009  2008 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2015-2019  2012-2016  2012-2016  2012-2016  2011-2013  2008-2013  2007-2011 
Nº of districts with microplans that include activities to raise immunization coverage number 63  63  63  62  63    62 

System performance

Total Nº districts in country number 63  63  63  62  63  60  62 
Nº districts with DTP3 coverage >=80% number 57  56  55  44  35  27  19 
% of districts with DTP3 coverage >=80% From 0 to 100% 90  89  87  71  56  45  31 
Nº districts with measles (MCV1) coverage >=95% number 23  35  34  31  21 
% of districts with MCV1 coverage >=95% From 0 to 100% 37  56  54  50  33  15 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 30  36  14  68   

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes     

Sources

 1  "The 2015 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.